Digital Pathology (Human & Animal) Market to Hit 12.1% CAGR to 2021 Led by Scanner Segment
The digital pathology market is expected to grow from USD 384.3 million in 2016 to USD 679.1 million by 2021, growing at a CAGR of 12.1% during the forecast period dominated by North America with largest market share.

Pune, India – June 3, 2016 /MarketersMedia/ —
Digital pathology is an image-based information environment that allows for the management of information generated from a digital slide. The growth of the overall digital pathology market can be contributed to the rising prevalence of chronic diseases, utilization of digital pathology for drug discovery and companion diagnostics, and growing initiatives by government and industry player’s to enhance pathological services.
Complete report on global digital pathology market spread across 152 pages, profiling 10 companies and supported with 78 tables and 41 figures is now available at http://www.reportsnreports.com/reports/195916-digital-pathology-market-slide-scanners-whole-slide-imaging-analytics-image-analysis-software-delivery-modes-web-based-cloud-based-and-whole-slide-image-storage-global-trends-forecast-till-2017.html .
The scanners segment is expected to account for the largest share of the digital pathology market, by product, in 2016. Digital pathology scanners create whole-slide images (WSI) from glass slides, converting the images into a digital form which helps to view, analyze, manage, share, and store them easily and efficiently, thus attributing to the largest share of the market.
The human pathology segment is expected to account for the largest share of the digital pathology market, by type, in 2016. The large share of this segment is mainly due to increasing utilization of digital pathology for chronic disease diagnosis. The pharmaceutical & biotechnology companies and CROs is expected to account for the largest share of the global digital pathology market, end user, in 2016.Pharmaceutical and biotechnology companies are using digital pathology in drug discovery and companion diagnostics, thus contributing to the largest share of this market. The teleconsultation segment is estimated to account for the largest share of the digital pathology market, by application, in 2016. Increasing demand for pathology consultation in underserved areas through telepath logy attributes to growth of this application.
North America is expected to account for the largest share of the global digital pathology market in 2016, followed by Europe, Asia-Pacific, and the Rest of the World (RoW).The large share of the North American region can be attributed to the presence of major pharmaceutical companies, increased cancer prevalence, presence of top market players, and growing government initiatives in Canada. The Asia-Pacific region is expected to witness the highest growth rate in the forecast period, mainly due to the growing chronic diseases prevalence, entry of top players and less stringent regulations in field of diagnostics.
The digital pathology market witnesses high competitive intensity, as there are several big and small firms with similar product offerings. These companies adopt various strategies (partnerships, joint ventures, collaborations, expansions, new product launches, and acquisition) to increase their market shares and establish a stronger foothold in the global market. Prominent players in the global digital pathology market are Leica Biosystems Nussloch GMBH (Germany), Ventana Medical Systems, Inc.(U.S.), Hamamatsu Photonics K.K (Japan), 3D Histech Ltd(Hungary)., Philips Healthcare (Netherlands), Apollo Enterprise Imaging Corp.(U.S.), Xifin, Inc.(U.S.), Definiens AG (Germany), Visiopharm A/S (Denmark), Omnyx, LLC.(U.S.), Corista LLC (U.S.).
Inquire for the discount before order a copy of Digital Pathology Market by Product (Scanners, Software), Type (Human, Animal Pathology), End User (Pharmaceutical Company, Hospital, Academic Institutions), Application (Teleconsultation, Drug Discovery) – Global Forecasts to 2021 research report at http://www.reportsnreports.com/contacts/discount.aspx?name=195916 .
The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help the garner a greater market, share. Firms purchasing the report could use any one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.
On a related note, another research on Tissue Diagnostics Market Global Forecast to 2020, says the global tissue diagnostics market is valued at USD 3,202.5 million in 2015 and expected to reach USD 4,471.1 million by 2020, at a CAGR of 6.9% from 2015 to 2020. The key drivers for this market are the increasing prevalence of cancer, growing geriatric population, and growing healthcare expenditure. The geographic segments included in this report are North America, Europe, Asia, and the Rest of the World (RoW). Companies like Abbott Laboratories, Agilent Technologies, BioGenex Laboratories, Bio SB, Cell Signaling Technology, Danaher Corporation, F. Hoffman-La Roche AG, Sigma-Aldrich, Thermo Fisher Scientificand Sakura Finetek Japan Co. have been profiled in this 169 pages research reports available at http://www.reportsnreports.com/reports/280675-tissue-diagnostics-market-by-technology-immunohistochemistry-in-situ-hybridization-digital-pathology-workflow-special-staining-disease-breast-cancer-gastric-cancer-lymphoma-prostate-cancer-non-small-cell-lung-cancer-and-others-product.html .
About Us:
ReportsnReports.com is an online market research reports library of 500,000+ in-depth studies of over 5000 micro markets. Not limited to any one industry, ReportsnReports.com offers research studies on agriculture, energy and power, chemicals, environment, medical devices, healthcare, food and beverages, water, advanced materials and much more.
For more information about us, please visit http://www.reportsnreports.com
Contact Info:
Name: Ritesh Tiwari
Organization: ReportsnReports
Address: UNIT no 802, Tower no. 7, SEZ Magarpatta city, Hadapsar – 411013
Phone: +1-888-391-5441
Release ID: 117785